✦ LIBER ✦

Diagnosis of carcinoma of the larynx: A review of current methods

✍ Scribed by M. Stuart Strong

Book ID: 115039878
Publisher: John Wiley and Sons
Year: 1975
Tongue: English
Weight: 380 KB
Volume: 85
Category: Article
ISSN: 0023-852X
DOI: 10.1288/00005537-197503000-00008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Carcinoma of the larynx — review of 100

Carcinoma of the larynx — review of 100 cases

✍ Norman E. Johnson; George A. Sisson 📂 Article 📅 1964 🏛 John Wiley and Sons 🌐 English ⚖ 535 KB

Carcinoma of the larynx. A review of 170

Carcinoma of the larynx. A review of 170 consecutive cases

✍ Dr. Willis S. Peck; Dr. James H. Maxwell; Dr. Frank Lamberson 📂 Article 📅 1941 🏛 John Wiley and Sons 🌐 English ⚖ 434 KB

Verrucous carcinoma of the larynx: A rev

Verrucous carcinoma of the larynx: A review of 53 patients

✍ Laura J. Orvidas; Kerry D. Olsen; Jean E. Lewis; Vera J. Suman 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB 👁 2 views

## Background: Verrucous carcinoma of the larynx is a rare laryngeal neoplasm that can be confused with a benign process. although usually curable at an early stage, it can be locally aggressive if left untreated. we describe our experience with this tumor and make recommendations for diagnosis and

Laboratory Diagnosis of HIV in Adults: A

Laboratory Diagnosis of HIV in Adults: A Review of Current Methods

✍ Cornett, J. K.; Kirn, T. J. 📂 Article 📅 2013 🏛 University of Chicago Press 🌐 English ⚖ 145 KB

Basaloid squamous cell carcinoma of the

Basaloid squamous cell carcinoma of the larynx—A systematic review

✍ Krishnakumar Thankappan 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 231 KB

Carcinoma of the Larynx

✍ Dr. A. G. Robertson; P. Boyle; F. Deuchars; C. Robertson 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 525 KB

Six hundred sixty-eight patients with tumours of the larynx were treated by radiotherapy. The patients had stage T1 NO MO to T4 N3 MO disease. Patients with T I NO MO disease ( 273) had an excellent long-term survival (90%) as did those with T2 NO MO disease (142), whose 5-year survival was 70%. Pat